Attached files
| file | filename |
|---|---|
| EX-23.1 - ProPhase Labs, Inc. | v214497_ex23-1.htm |
| EX-32.2 - ProPhase Labs, Inc. | v214497_ex32-2.htm |
| EX-32.1 - ProPhase Labs, Inc. | v214497_ex32-1.htm |
| EX-31.1 - ProPhase Labs, Inc. | v214497_ex31-1.htm |
| EX-23.2 - ProPhase Labs, Inc. | v214497_ex23-2.htm |
| EX-31.2 - ProPhase Labs, Inc. | v214497_ex31-2.htm |
| 10-K - ProPhase Labs, Inc. | v214497_10k.htm |
EXHIBIT 21.1
SUBSIDIARIES OF PROPHASE LABS, INC.
|
State or other
|
||||||
|
Jurisdiction of
|
Ownership
|
|||||
|
Subsidiaries
|
Incorporation
|
Percentage
|
||||
|
Pharmaloz Manufacturing Inc.
|
Delaware
|
100 | % | |||
|
Phusion Laboratories, LLC
|
Delaware
|
50 | % | |||
|
Quigley Pharma Inc.
|
Delaware
|
100 | % | |||
The above subsidiaries are included in the consolidated financial statements for the year ended December 31, 2010.